vadimezan has been researched along with diphenyleneiodonium in 1 studies
| Studies (vadimezan) | Trials (vadimezan) | Recent Studies (post-2010) (vadimezan) | Studies (diphenyleneiodonium) | Trials (diphenyleneiodonium) | Recent Studies (post-2010) (diphenyleneiodonium) |
|---|---|---|---|---|---|
| 272 | 16 | 101 | 855 | 1 | 308 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fitzgerald, KA; Lai, W; Perkins, DJ; Prantner, D; Sharma, S; Vogel, SN; Williams, MS | 1 |
1 other study(ies) available for vadimezan and diphenyleneiodonium
| Article | Year |
|---|---|
5,6-Dimethylxanthenone-4-acetic acid (DMXAA) activates stimulator of interferon gene (STING)-dependent innate immune pathways and is regulated by mitochondrial membrane potential.
Topics: Animals; Antineoplastic Agents; Enzyme Inhibitors; Immunity, Innate; Interferon-beta; Interleukin-6; Macrophages, Peritoneal; Membrane Glycoproteins; Membrane Potential, Mitochondrial; Membrane Proteins; Mice; Mice, Knockout; NADPH Oxidase 2; NADPH Oxidases; Onium Compounds; Oxidants; Signal Transduction; Tumor Necrosis Factor-alpha; Up-Regulation; Xanthones | 2012 |